Search Results 2041-2050 of 39156 for Two-phase

  1. Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. Fatty liver disease (MASLD) diet - Mayo Clinic

    Focus on nonstarchy vegetables such as asparagus, broccoli, carrots and spinach. Limit starchy vegetables such as potatoes. Fruits. Get at least two servings of ...

  3. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  4. Morning sickness - Diagnosis and treatment - Mayo Clinic

    If these steps don't help, ask your health care provider about other ways ... 2020; https://www-cfp-ca.mclibrary.idm.oclc.org/content/66/2/98. Accessed ...

  5. A Study to Evaluate the Safety and Effectiveness of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma Patients - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  6. Polyhydramnios - Symptoms and causes - Mayo Clinic

    Polyhydramnios happens in about 1% to 2% of pregnancies. Most of the time, the condition is mild. It's often found during the middle or later stages of ...

  7. A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Panobinostat in Treating Patients with Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. To Assess Safety, Tolerability And Efficacy Of LJN452 In Patients With Primary Bile Acid Diarrhea. - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...